Optiray (Ioversol)

• Optiray is an iodinated contrast agent used in radiographic procedures to improve image quality.
• CT imaging: provides enhanced contrast for better visualization of anatomical structures.
• Angiography: improves delineation of blood vessels during vascular studies.
• Myelography: facilitates clear imaging of the spinal canal and surrounding tissues.

• Ioversol contains iodine atoms that strongly absorb X‑ray photons, increasing radiodensity of blood and extracellular fluid. After intravenous injection, the agent distributes rapidly throughout the vascular and interstitial spaces, temporarily highlighting vessels and organs during imaging. Its non‑ionic, low‑osmolality formulation reduces viscosity and minimizes physiologic disturbance while providing high‑contrast enhancement.

Adverse reactions may occur following administration of iodinated contrast agents.

Common Side Effects

• Warmth or flushing sensation at the injection site.
• Nausea or mild vomiting.
• Transient metallic taste in the mouth.
• Mild headache or dizziness.
• Injection site pain or bruising.
• Mild urticaria or itching.

Serious or Rare Side Effects

• Anaphylactic or severe allergic reaction.
• Acute renal impairment, especially in patients with pre‑existing kidney disease.
• Severe hypotension or cardiovascular collapse.
• Pulmonary edema or respiratory distress.
• Cardiac arrhythmias.
• Seizures or neurologic disturbances.

• Prior to using Optiray, clinicians should assess patient risk factors and follow safe handling practices.
• Assess renal function: evaluate serum creatinine and eGFR before administration.
• Check iodine allergy history: obtain detailed patient allergy information.
• Ensure adequate hydration: encourage fluid intake before and after the procedure.
• Avoid in uncontrolled hyperthyroidism: consider risk of iodine load.
• Pregnancy: use only when essential and benefits outweigh risks.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Ioversol may interact with certain medications, requiring caution.

Major Interactions (Avoid)

• Nephrotoxic drugs: concurrent high‑dose aminoglycosides may exacerbate kidney injury.
• Metformin: discontinue in patients with impaired renal function to prevent lactic acidosis.
• Other iodine‑containing agents: avoid simultaneous use to reduce cumulative iodine load.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask contrast‑induced tachycardia.
• Diuretics: monitor fluid balance and electrolytes.
• ACE inhibitors or ARBs: watch for changes in renal function after contrast exposure.